Filtration Fraction and its Implications for Radionuclide Renography Using Diethylenetriaminepentaacetic Acid and Mercaptoacetyltriglycine

Clinical Nuclear Medicine

Volumn 29, Issue 4, 2004, Pages 231-237

  Gates, Gary F ^a  

^a PROVIDENCE ST VINCENT MEDICAL CENTER   (United States)

Author keywords

DTPA; Filtration fraction; MAG3; Radionuclide renography; Renal imaging protocols

Indexed keywords

IODOHIPPURATE SODIUM I 131; MERTIATIDE TC 99M; PENTETATE TECHNETIUM TC 99M; RADIOISOTOPE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY PLASMA FLOW; MAJOR CLINICAL STUDY; MALE; RENOGRAPHY; RENOVASCULAR DISEASE; SCINTILLATION CAMERA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGING; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; RENAL CIRCULATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEX FACTORS; TECHNETIUM TC 99M MERTIATIDE; TECHNETIUM TC 99M PENTETATE;

EID: 1542638317     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000117998.67737.ae     Document Type: Article

References (37)

1. Lee VS, Rusinek H, Johnson G, et al. MRI renography with low-dose gadopentetate dimeglumine: feasibility. Radiology. 2001;221:271.
2. Hackstein N, Bauer J, Hauck EW, et al. Measuring single-kidney glomerular filtration rate on single-detector helical CT using a two-point Patlak plot technique in patients with increased interstitial space. Am J Roentgenol. 2003;181:147.
3. Kassirer JP, Gennari FJ. Laboratory evaluation of renal function. In: Earley LE, Gottschalk CW, eds. Strauss & Welt's Diseases of the Kidney, 3rd ed. Boston: Little, Brown and Co; 1979:41-91.
4. Levey AS, Madaio MP, Perrone RD. Laboratory assessment of renal disease: clearance, urinalysis, and renal biopsy. In: Brenner BM, Rector FC Jr, eds. The Kidney, 4th ed, vol I. Philadelphia: WB Saunders; 1991:919-968.
5. Brown SCW, O'Reilly PH. Glomerular filtration rate measurement: a neglected test in urological practice. Br J Urol. 1995;75:296.
6. Kasiske BL, Keane WF. Laboratory assessment of renal disease: clearance, urinalysis, and renal biopsy. In: Brenner BM, ed. Brenner & Rector's The Kidney, 6th ed. Philadelphia: WB Saunders; 2000:1129-1170.
7. Schlegel JU, Halikiopoulos HL, Prima R. Determination of filtration fraction using the gamma scintillation camera. J Urol. 1979;122:447.
8. Guyton AC. Textbook of Medical Physiology, 8th ed. Philadelphia: WB Saunders; 1991:286-307.
9. Ganong WF. Review of Medical Physiology, 8th ed. Los Altos: Lange Medical Publications; 1977:528.
10. Schlegel JU, Lang EK. Computed radionuclide urogram for assessing acute renal failure. Am J Roentgenol. 1980;134:1029.
11. Schelgel JU, Hamway SA. Individual renal plasma flow determination in 2 minutes. J Urol. 1976;116:282.
12. Gates GF. Glomerular filtration rate: estimation from fractional renal accumulation of 99mTc-DTPA (stannous). Am J Roentgenol. 1982;138: 565.
13. Gates GF. Split renal function testing using Tc-99m DTPA. A rapid technique for determining differential glomerular filtration. Clin Nucl Med. 1983;8:400.
14. Gates GF. Glomerular filtration. In Henkin RE, et al., eds. Nuclear Medicine. St. Louis: Mosby; 1996:1065-1083.
15. O'Malley JP, Ziessman HA, Chantarapitak N. Tc-99m MAG3 as an alternative to Tc-99m DTPA and I-131 hippuran for renal transplant evaluation. Clin Nucl Med. 1993;18:22.
16. Taylor A, Nally JV. Clinical applications of renal scintigraphy. Am J Roentgenol. 1995;164:31.
17. Smith HW, Finkelstein N, Alimosa L, et al. The renal clearances of substituted hippuric acid derivatives and other aromatic acids in dog and man. J Clin Invest. 1945;24:388.
18. Chervu LR, Freeman LM, Blaufox MD. Radiopharmaceuticals for renal studies. Semin Nucl Med. 1974;4:3.
19. Eshima D, Taylor A Jr. Technetium-99m (Tc-99m) mercaptoacetyltriglycine: update on the new Tc-99m renal tubular function agent. Semin Nucl Med. 1992;22:61.
20. Tauxe WN. Tubular function. In: Tauxe WN, Dubovsky EV, eds. Nuclear Medicine in Clinical Urology and Nephrology. Norwalk, CT: Appleton-Century-Crofts; 1985:77-105.
21. Moran JK. Technetium-99m-EC and other potential new agents in renal nuclear medicine. Semin Nucl Med. 1999;29:91.
22. Taylor A. Radionuclide renography: a personal approach. Semin Nucl Med. 1999;29:102.
23. Taylor A Jr, Ziffer JA, Steves A, et al. Clinical comparison of I-131 orthoiodohippurate and the kit formation of Tc-99m mercaptoacetyltriglycine. Radiology. 1989;170:721.
24. Russell CD, Taylor A, Eshima D. Estimation of technetium-99m-MAG3 plasma clearance in adults from one or two blood samples. J Nucl Med. 1989;30:1955.
25. 3. J Nucl Med. 1991;32:2061.
26. Klingensmith WC III, Briggs DE, Smith WI. Technetium-99m-MAG3 renal studies: normal range and reproducibility of physiologic parameters as a function of age and sex. J Nucl Med. 1994;35:1612.
27. Smith HW. The Kidney: Structure and Function in Health and Disease. New York: Oxford University Press; 1951:544-545.
28. Pitts RF. Physiology of the Kidney and Body Fluids. Chicago: Year Book Medical Publishers; 1963:202-214.
29. PAH in healthy donors before and after nephrectomy. Mayo Clin Proc. 1976;51:296.
30. Davies DF, Shock NW. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest. 1950;29:496.
31. Levi M, Rowe JW. Renal function and dysfunction with aging. In: Seldin DW, Giebisch G, eds. The Kidney: Physiology and Pathophysiology, 2nd ed. New York: Raven Press; 1992:3433-3456.
32. TM. J Nucl Med Tech. 1991;19:147.
33. Texor SC. Renal failure related to angiotensin-converting enzyme inhibitors. Semin Nephrol. 1997;17:67.
34. McAfee JG. Update on radiopharmaceuticals for medical imaging. Radiology. 1989;171:593.
35. Gates GF, Green GS. Transient reduction in renal function following arteriography: a radionuclide study. J Urol. 1983;129:1107.
36. Taylor A Jr, Eshima, D, Christian PE, et al. Evaluation of Tc-99m mercaptoacetyltriglycine in patients with impaired renal function. Radiology. 1987;162:365.
37. 99mTc renal tubular function agents: current status. Semin Nucl Med. 1990;20:28.